Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001933414-23-000093
Filing Date
2023-11-27
Accepted
2023-11-27 16:01:13
Documents
1
Period of Report
2023-11-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1701118862.html 4  
1 FORM 4 wk-form4_1701118862.xml 4 3587
  Complete submission text file 0001933414-23-000093.txt   4966
Mailing Address 3122 STERLING CIRCLE, SUITE 200 BOULDER CO 80301
Business Address
Congleton Jon (Reporting) CIK: 0001644975 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41614 | Film No.: 231440257

Mailing Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087
Business Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087 (888) 378-6240
Mineralys Therapeutics, Inc. (Issuer) CIK: 0001933414 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations